Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

Phase 1 Trial of Pegzilarginase in Patients (pts) with Relapsed/refractory (R/R) AML or MDS Refractory to Hypomethylating Agents (Hmas).

Geoffrey L. Uy,Michael R. Savona,Benjamin K. Tomlinson,Hetty Carraway,Dale L. Bixby,Sarit E. Assouline,Joseph M. Brandwein,Moshe Yair Levy,Robert Collins,Humberto Lara-Guerra,Susan Alters,Stephen Eckert,Scott Rowlinson,James Wooldridge,Aaron David Schimmer

Journal of clinical oncology（2018）

Cited 3|Views50

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined